Association Between Liver Enzymes and Metabolic Syndrome: A Population‐Based Cross‐Sectional Study of the Bandar Kong Cohort Study
International Journal of Hepatology · 2026-01 · 2026 (1)
DOI: 10.1155/ijh/8920064 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Hepatology, online erschienen am 08.04.2026. Verfasst von Arezoo Ghazalgoo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran, hums.ac.ir. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS) is a major global health concern that increases morbidity and mortality from cardiometabolic diseases. We refined the rationale to highlight the mechanistic involvement of the liver in metabolic dysregulation.
Methods
This population‐based study was conducted on 3896 adults aged between 35 and 70 (57.2% female) who participated in the Bandare‐Kong Non‐Communicable Diseases (BKNCD) cohort study. Participants were categorized into normal quartiles and abnormal levels of liver enzymes including gamma‐glutamyl transferase (GGT), alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP). MetS was defined based on the modified National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria for Iranian population. Logistic regression was used to calculate odds ratios (ORs) with 95% confidence intervals (CIs) and p values, adjusting for age, sex, residence, BMI, physical activity, energy intake, and financial status.
Results
The prevalence of MetS was 36.6%. After multivariable adjustment, abnormal levels of GGT (OR = 1.91, 95% CI: 1.61–2.28, p < 0.001), ALT (OR = 1.60, 95% CI: 1.34–1.90, p < 0.001), ALP (OR = 1.48, 95% CI: 1.07–2.03, p = 0.01), and AST (OR = 1.39, 95% CI: 1.09–1.77, p = 0.007) were significantly associated with higher odds of MetS. Within normal ranges, the highest quartile of GGT (OR = 2.81, 95% CI: 2.22–3.56, p < 0.001), ALT (OR = 2.39, 95% CI: 1.89–3.03, p < 0.001), and ALP (OR = 1.63, 95% CI: 1.30–2.04, p < 0.001) showed significant associations, while AST did not.
Conclusion
Serum liver enzyme levels, including those within normal range, were strongly associated with MetS. GGT showed relatively stronger associations compared with other enzymes; however, these findings should not be interpreted as diagnostic superiority because no performance metrics (AUC, PPV, and NPV) were evaluated. ALT and ALP also showed meaningful associations. Future studies should assess diagnostic accuracy before considering clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran, hums.ac.ir.
- Department of Cardiology, Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran, hums.ac.ir.
- Student Research Committee, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran, hums.ac.ir.
- Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran, gums.ac.ir.
- Department of Gastroenterology and Hepatology, Hormozgan University of Medical Sciences, Bandar Abbas, Iran, hums.ac.ir.
ORCID-Profile: Seyyed Mohammad Hashemi, Ehsan Amini-Salehi, Hoda Safa
Zitieren
APA
Ghazalgoo, A., Kheirandish, M., Hashemi, S. M., Salarpour, E., Basham, A., Saberian, P., Amini-Salehi, E., & Safa, H. (2026). Association Between Liver Enzymes and Metabolic Syndrome: A Population‐Based Cross‐Sectional Study of the Bandar Kong Cohort Study. International Journal of Hepatology, 2026(1). https://doi.org/10.1155/ijh/8920064
Vancouver
Ghazalgoo A, Kheirandish M, Hashemi SM, Salarpour E, Basham A, Saberian P, et al. Association Between Liver Enzymes and Metabolic Syndrome: A Population‐Based Cross‐Sectional Study of the Bandar Kong Cohort Study. International Journal of Hepatology. 2026;2026(1). doi:10.1155/ijh/8920064
BibTeX
@article{Ghazalgoo2026,
author = {Ghazalgoo, Arezoo and Kheirandish, Masoumeh and Hashemi, Seyyed Mohammad and Salarpour, Elaheh and Basham, Ayoub and Saberian, Parsa and Amini-Salehi, Ehsan and Safa, Hoda},
title = {Association Between Liver Enzymes and Metabolic Syndrome: A Population‐Based Cross‐Sectional Study of the Bandar Kong Cohort Study},
journal = {International Journal of Hepatology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijh/8920064}
}
EUVIMED